⌘K

Login Start Free

Home/Filings/4/0001104659-26-001384

4//SEC Filing

MONAHAN JOHN J 4

Accession 0001104659-26-001384

CIK 0000894158other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:54 PM ET

Size

5.8 KB

Accession

0001104659-26-001384

Insider Transaction Report

Form 4

Period: 2026-01-05

Theriva Biologics, Inc.TOVX

Director

Transactions

Award
Stock Options (right to buy)
2026-01-05+75,000→ 75,000 total
Exercise: $0.24From: 2026-02-01Exp: 2033-01-04→ Common Stock (75,000 underlying)

Footnotes (1)

[F1]These stock options vest pro rata on a monthly basis over 12 months.

Documents

1 file

4
tm262266-3_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Theriva Biologics, Inc.

CIK 0000894158

Entity typeother

Related Parties

1

filerCIK 0001257825

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 4:54 PM ET
Size: 5.8 KB

View on SEC.gov